- Home
- CCLD vs ADAG Comparison
CCLD vs ADAG Comparison
Compare CCLD & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- ADAG
- Stock Information
- Founded
- CCLD 1999
- ADAG 2011
- Country
- CCLD United States
- ADAG China
- Employees
- CCLD N/A
- ADAG N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- CCLD Technology
- ADAG Health Care
- Exchange
- CCLD Nasdaq
- ADAG Nasdaq
- Market Cap
- CCLD 105.8M
- ADAG 91.4M
- IPO Year
- CCLD 2014
- ADAG 2021
- Fundamental
- Price
- CCLD $2.40
- ADAG $1.92
- Analyst Decision
- CCLD Buy
- ADAG Strong Buy
- Analyst Count
- CCLD 2
- ADAG 1
- Target Price
- CCLD $3.00
- ADAG $8.00
- AVG Volume (30 Days)
- CCLD 488.2K
- ADAG 51.3K
- Earning Date
- CCLD 08-12-2025
- ADAG 07-24-2025
- Dividend Yield
- CCLD N/A
- ADAG N/A
- EPS Growth
- CCLD N/A
- ADAG N/A
- EPS
- CCLD N/A
- ADAG N/A
- Revenue
- CCLD $112,507,000.00
- ADAG $103,204.00
- Revenue This Year
- CCLD $2.74
- ADAG $6,488.89
- Revenue Next Year
- CCLD $7.52
- ADAG $57.50
- P/E Ratio
- CCLD N/A
- ADAG N/A
- Revenue Growth
- CCLD N/A
- ADAG N/A
- 52 Week Low
- CCLD $1.14
- ADAG $1.33
- 52 Week High
- CCLD $4.84
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- CCLD 55.83
- ADAG 56.78
- Support Level
- CCLD $2.29
- ADAG $1.74
- Resistance Level
- CCLD $2.48
- ADAG $1.98
- Average True Range (ATR)
- CCLD 0.15
- ADAG 0.12
- MACD
- CCLD -0.01
- ADAG -0.00
- Stochastic Oscillator
- CCLD 53.13
- ADAG 72.22
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.